ArticleCureus2026
Acute Kidney Injury Following Whole Cherry Consumption as a Sleep Aid in a Geriatric Patient With Chronic Kidney Disease.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cherries are consumed for their anti-inflammatory and sleep-promoting effects, but their potential adverse effects remain poorly characterized. A 95-year-old woman with stage 3A chronic kidney disease (CKD) presented with an increase in serum creatinine from a baseline of 0.8 to 1.3 mg/dL and a decrease in estimated glomerular filtration rate from 55.3 to 35.2 mL/min/1.73 m² following two weeks of consuming 15-20 fresh or frozen whole cherries nightly. Cherry consumption was discontinued, and her kidney function returned to baseline one month later. Cherries contain high amounts of anthocyanins, which may contribute to acute kidney injury (AKI) in CKD patients through cyclooxygenase (COX)-inhibitory mechanisms, similar to nonsteroidal anti-inflammatory drugs (NSAIDs). Application of the Naranjo Adverse Drug Reaction Probability Scale yielded a score of 7, indicating a "probable" association between cherry consumption and AKI.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.